1. Summary Information

 

 

Country

India

Company Name

POLYDRUG LABORATORIES PRIVATE LIMITED

Principal Name 1

Mr. Chunilal K Thakrar

Status

Satisfactory

Principal Name 2

Mr. Punit C Thakrar

 

 

Registration #

11-147729

Street Address

A-201/202, Nav Bharat Estate, Zakaria Bunder Road, Sewri (West), Mumbai – 400 015, Maharashtra

Established Date

28.07.2004

SIC Code

--

Telephone#

91-22-24106001

Business Style 1

Manufacturers

Fax #

91-22-24106008

Business Style 2

--

Homepage

http://www.polydrug.com

Product Name 1

Pharmaceutical Bulk Drugs

# of employees

Not Available

Product Name 2

--

Paid up capital

Rs.86,995,050/-

Product Name 3

--

Shareholders

Directors or relatives of Directors – 99.93%, Other top fifty shareholders – 0.07%

Banking

Tamilnad Mercantile Bank Limited

Public Limited Corp.

No

Business Period

8 Years

IPO

No

International Ins.

-

Public Enterprise

No

Rating

Ba (46)

Related Company

Relation

Country

Company Name

CEO

Associates

--

Polydrug Laboratories

--

Note

-

2. Summary Financial Statement

Balance Sheet as of

31.03.2011

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

271,403,000

Current Liabilities

92,363,000

Inventories

90,891,000

Long-term Liabilities

287,981,000

Fixed Assets

218,875,000

Other Liabilities

26,114,000

Deferred Assets

0,000

Total Liabilities

 406,458,000

Invest& other Assets

314,000

Retained Earnings

88,030,000

 

 

Net Worth

175,025,000

Total Assets

581,483,000

Total Liab. & Equity

581,483,000

 Total Assets

(Previous Year)

532,244,000

 

 

P/L Statement as of

31.03.2011

(Unit: Indian Rs.)

Sales

NA

Net Profit

35,851,000

Sales(Previous yr)

709,301,000

Net Profit(Prev.yr)

33,627,000

MIRA INFORM REPORT

 

 

Report Date :

06.02.2012

 

IDENTIFICATION DETAILS

 

Name :

POLYDRUG LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

A-201/202, Nav Bharat Estate, Zakaria Bunder Road, Sewri (West), Mumbai – 400 015, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

28.07.2004

 

 

Com. Reg. No.:

11-147729

 

 

Capital Investment / Paid-up Capital :

Rs.86.995 Millions

 

 

CIN No.:

[Company Identification No.]

U24231MH2004PTC147729

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMP18857G

 

 

PAN No.:

[Permanent Account No.]

AADCP3618H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturers of Pharmaceutical Bulk Drugs

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 700000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track records. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office :

A-201/202, Nav Bharat Estate, Zakaria Bunder Road, Sewri (West), Mumbai – 400 015, Maharashtra, India

Tel. No.:

91-22-24106001

Fax No.:

91-22-24106008

E-Mail :

accounts@dharmesh@polydrug.com

accounts@gemini-exports.com

dharmesh@polydrug.com

Website :

http://www.polydrug.com

Area :

3000 Sq. ft.

Location :

Owned

 

 

Factory  :

Ambernath Industrial Area, Plot No. 37, Anand Nagar, MIDC, Ambernath – 421 506, Maharashtra, India

E-Mail :

polydrug@polydrug.com

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Chunilal Kalidas Thakrar

Designation :

Director

Address :

513/A, Arun Building, College Road, Matunga, Mumbai – 400 019, Maharashtra, India

Date of Birth/Age :

21.05.1933

Date of Appointment :

28.07.2004

Din No.:

00351566

 

 

Name :

Mr. Punit Chunilal Thakrar

Designation :

Director

Address :

513/A, Arun Building, College Road, Matunga, Mumbai – 400 019, Maharashtra, India

Date of Birth/Age :

17.06.1967

Date of Appointment :

28.07.2004

Din No.:

00351619

 

 

Name :

Mrs. Bina Punit Thakrar

Designation :

Director

Address :

513/A, Arun Building, College Road, Matunga, Mumbai – 400 019, Maharashtra, India

Date of Birth/Age :

14.11.1970

Date of Appointment :

28.07.2004

Din No.:

00351627

 

 

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders (Equity Shares)

 

No. of Shares

Thakrar K. Chunilal

 

520000

Thakrar C. Chandrika

 

232500

Thakrar C. Punit

 

1820500

Thakrar P. Bina

 

922500

Ms. Karina Punit Thakrar (Guardian Mr. Punit C. Thakrar)

 

1000

Mrs. Varsha Kumari

 

1000

Thaakrar C. Punit/ Thakrar P.Bina

 

500000

Mrs. Hema Dilip Lakhani / Ms. Kajal Dilip Lakhani

 

2500

TOTAL

 

4000000

 

Names of Shareholders (Preference Share)

 

No. of Shares

Openplus SA.

 

1832000

M/s. Far East Century Private Limited, Singapore

 

954360

Openplus SA.

 

1913145

TOTAL

 

4699505

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2011

 

Category

Percentage

Directors or relatives of Directors

99.93

Other top fifty shareholders

0.07

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of Pharmaceutical Bulk Drugs

 

 

Products :

Chlorobutanol

  • Anhydrous
  • Hemihydrate
  • Ferrous Fumarate
  • Fluconazole
  • Lidocaine Base / hydrochloride
  • Losartan Potassium
  • Metoprolol Succinate
  • Metoprolol Tartarate

 

Pellets

  • Metoprolol Succinate
  • Pantoprazole Sodium

 

 

Direct Compression

  • Ferrous Fumarate
  • Fluconazole
  • Metoprolol Succinate
  • Metoprolol Tartarate

 

 

Micoencapsulated

  • Ferrous Fumarate

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Tamilnad Mercantile Bank Limited, Hemprakash Building, Ground Floor, 92, Kazi Syed Street, Mandvi, Masjid, Mumbai – 400 003, Maharashtra, India

 

 

Facilities :

Secured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

Rupee term loans banks secured

40.687

94.369

Foreign currency loans banks secured

10.015

0.000

Loans taken for fixed assets secured

0.529

0.887

Finance lease obligation long-term secured

162.280

122.990

Total

213.511

218.246

 

 

Unsecured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

Loans subsidiaries unsecured

38.859

16.742

Other debt unsecured

35.611

26.021

Total

74.470

42.763

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Lakhani and Company

Chartered Accountants

Address :

Jeevan Udyog, 278, D N Road, 2nd Floor, Above Khadhi Bhandar, Fort, Mumbai – 400 001, Maharashtra, India

PAN.:

AAAFL1302L

 

 

Key Management Personnel :

  • Polydrug Laboratories
  • Gemini Export

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

6000000

Preferences Share

Rs.10/- each

Rs.60.000 Millions

 

TOTAL

 

Rs.100.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

4699505

Preferences Share

Rs.10/- each

Rs.46.995 Millions

 

TOTAL

 

Rs.86.995 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

86.995

92.175

92.175

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

88.030

52.178

18.552

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

175.025

144.353

110.727

LOAN FUNDS

 

 

 

1] Secured Loans

213.511

218.246

225.453

2] Unsecured Loans

74.470

42.763

39.825

TOTAL BORROWING

287.981

261.009

265.278

DEFERRED TAX LIABILITIES

16.362

16.074

11.349

 

 

 

 

TOTAL

479.368

421.436

387.354

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

218.875

230.832

240.399

Capital work-in-progress

0.314

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

90.891

59.413

43.900

 

Sundry Debtors

232.303

198.138

168.164

 

Cash & Bank Balances

5.074

14.471

2.373

 

Other Current Assets

22.803

18.794

25.455

 

Loans & Advances

11.223

10.596

6.972

Total Current Assets

362.294

301.412

246.864

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

75.819

82.297

72.736

 

Other Current Liabilities

16.544

22.974

25.876

 

Provisions

9.752

5.537

3.297

Total Current Liabilities

102.115

110.808

101.909

Net Current Assets

260.179

190.604

144.955

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.00

 

 

 

 

TOTAL

479.368

421.436

387.354

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

709.301

521.667

 

 

Other Income

 

 

 

 

 

TOTAL                                    

 

709.301

521.667

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

660.032

497.213

 

 

Administrative Expenses

NA

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

 

660.032

497.213

 

 

 

 

 

 

PROFIT BEFORE TAX

 

49.269

24.454

 

 

 

 

 

Less

TAX                                                                 

 

15.642

7.525

 

 

 

 

 

 

PROFIT AFTER TAX

35.851

33.627

16.929

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

538.977

609.864

463.320

 

TOTAL EARNINGS

538.977

609.846

463.320

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

67.681

60.549

 

 

Capital Goods

NA

0.000

0.794

 

TOTAL IMPORTS

NA

67.681

61.343

 

 

 

 

 

 

Earnings Per Share (Rs.)

8.96

8.41

4.23

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

NA

4.74

3.25

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

9.26

5.03

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.34

0.22

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.23

2.58

3.29

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.55

2.72

2.48

 

LOCAL AGENCY FURTHER INFORMATION

 

FORM 8

 

Corporate identity number of the company

U24231MH2004PTC147729

Name of the company

POLYDRUG LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Address : A-201/202, Navbharat Estate, Zakaria Bunder Road, Sewri (West), Mumbai – 400 015, Maharashtra, India

Email : dharmesh@polydrug.com

This form is for

Creation of charge

Type of charge

  • Immovable Property
  • Movable Property

Particular of charge holder

Tamilnad Mercantile Bank, Gordia House, 1st Floor, 101-104, Kazi Syed Street, Mandvi, Masjid, Mumbai – 400 003, Maharashtra, India

Email : mumbai_mandvi@tnmboline.com

Nature of instrument creating charge

1. Deed of hypothecation of machinery, accessories and tools executed on 17th January 2012.

 

2. Mortgage extension letter dated 17th January 2012 executed by the company in favour of bank for extending the scope of mortgage for the present facility.

Date of instrument Creating the charge

17.01.2012

Amount secured by the charge

Rs.55.400 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

Base rate + 3.00% (presently 13.75%) till 31.12.2012 and thereafter as per credit rating.

 

Terms of Repayment:

Repayment in 60 EMI. Payment of first EMI starts from 17th February 2013.

Emi amount - for 1 to 59 EMI Rs.923.000 millions and 60th EMI of Rs.923.000 millions

 

Margin:

30%

Extent and Operation of the charge:

The present facility is granted for purchase of machineries.

 

A hypothecation on the machineries / accessories to be purchased under the present facility and collateral security by way of extension of mortgage on the existing land and factory building as more particularly provided in therein is provided as security to secure the repayment of loan of Rs.55.400 millions along with interest payable thereon.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Hypothecation of machinery, accessories and tools having value of Rs.79.454 millions to be purchased under the present credit facility.

 

Extension of equitable mortgage on the factory land at plot no. N-37, additional Ambarnath industrial area, Ambarnath admeasuring 24558 sq. Mtrs.

 

Extension of equitable mortgage on the factory building constructed on land at Plot No. N-37, additional Ambarnath industrial area, Ambarnath admeasuring 6887.01 sq. Mtrs.

 

Extension of equitable mortgage on the factory building to be constructed on land at plot no. N-37, additional Ambarnath industrial area, Ambarnath admeasuring 7962.40 sq. Ft.

 

FIXED ASSETS

 

·         Leasehold Premises

·         Factory Building

·         Plant and Machinery

·         D and G Set

·         Elevators

·         Fire Equipments

·         Air Handling Unit

·         Hosts and Cranes

·         Lab Equipments

·         Sewing Machine

·         Transformer

·         Wrapping Machine

·         HVAC Equipments

·         Air Condition

·         Computers

·         Elect Fitting

·         Fridge

·         Furniture

·         Motor Cycle

·         Telephone Instruments

·         Vaccum Cleaner

·         Water Filter

·         Xerox Machine

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.48.96

UK Pound

1

Rs.77.47

Euro

1

Rs.64.40

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.